These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30061039)

  • 1. Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.
    Zeki J; Taylor JS; Yavuz B; Coburn J; Ikegaki N; Kaplan DL; Chiu B
    Surgery; 2018 Oct; 164(4):909-915. PubMed ID: 30061039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.
    Coburn J; Harris J; Zakharov AD; Poirier J; Ikegaki N; Kajdacsy-Balla A; Pilichowska M; Lyubimov AV; Shimada H; Kaplan DL; Chiu B
    Int J Cancer; 2017 Feb; 140(3):726-735. PubMed ID: 27770551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.
    Taylor JS; Yavuz B; Zeki J; Wood L; Ikegaki N; Coburn J; Harrington K; Shimada H; Kaplan DL; Chiu B
    Surgery; 2020 Jun; 167(6):969-977. PubMed ID: 32122657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model.
    Ornell KJ; Taylor JS; Zeki J; Ikegaki N; Shimada H; Coburn JM; Chiu B
    Cancer Med; 2020 Apr; 9(8):2891-2903. PubMed ID: 32096344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.
    Coburn JM; Harris J; Cunningham R; Zeki J; Kaplan DL; Chiu B
    J Pediatr Surg; 2017 Dec; 52(12):2061-2065. PubMed ID: 28927981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth.
    Harris JC; Coburn JM; Kajdacsy-Balla A; Kaplan DL; Chiu B
    J Pediatr Surg; 2016 Dec; 51(12):2058-2062. PubMed ID: 27680598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression.
    Taylor JS; Zeki J; Ornell K; Coburn J; Shimada H; Ikegaki N; Chiu B
    J Pediatr Surg; 2019 Jun; 54(6):1192-1197. PubMed ID: 30879743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.
    Yavuz B; Zeki J; Coburn JM; Ikegaki N; Levitin D; Kaplan DL; Chiu B
    J Control Release; 2018 Sep; 285():162-171. PubMed ID: 30018030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations.
    Yavuz B; Zeki J; Taylor J; Harrington K; Coburn JM; Ikegaki N; Kaplan DL; Chiu B
    J Pharm Sci; 2019 Aug; 108(8):2748-2755. PubMed ID: 30905702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.
    Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS
    Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.
    Chiu B; Coburn J; Pilichowska M; Holcroft C; Seib FP; Charest A; Kaplan DL
    Br J Cancer; 2014 Aug; 111(4):708-15. PubMed ID: 24921912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo.
    Seib FP; Coburn J; Konrad I; Klebanov N; Jones GT; Blackwood B; Charest A; Kaplan DL; Chiu B
    Acta Biomater; 2015 Jul; 20():32-38. PubMed ID: 25861948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma.
    Viale M; Bertone V; Maric I; Cilli M; Emionite L; Bocchini V; Ponzoni M; Fontana V; De Luca F; Rocco M
    Pharmacol Res; 2021 Jan; 163():105294. PubMed ID: 33217536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicating and identifying large cell neuroblastoma using high-dose intra-tumoral chemotherapy and automated digital analysis.
    Taylor JS; Sha L; Ikegaki N; Zeki J; Deaton R; Harris J; Coburn J; Yavuz B; Sethi A; Shimada H; Kaplan DL; Gann P; Chiu B
    J Pediatr Surg; 2019 Dec; 54(12):2595-2599. PubMed ID: 31519361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin gels entrapment of a doxorubicin-containing targeted polycyclodextrin: Evaluation of in vivo antitumor activity in orthotopic models of human neuroblastoma.
    Viale M; Vecchio G; Maric I; Cilli M; Aprile A; Ponzoni M; Fontana V; Priori EC; Bertone V; Rocco M
    Toxicol Appl Pharmacol; 2019 Dec; 385():114811. PubMed ID: 31705944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis of vincristine loaded silk fibroin hydrogel for sustained drug delivery applications: Multiphysics modeling and experiments.
    Gharehnazifam Z; Dolatabadi R; Baniassadi M; Shahsavari H; Kajbafzadeh AM; Abrinia K; Baghani M
    Int J Pharm; 2021 Nov; 609():121184. PubMed ID: 34648880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
    Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
    Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
    Zuccari G; Milelli A; Pastorino F; Loi M; Petretto A; Parise A; Marchetti C; Minarini A; Cilli M; Emionite L; Di Paolo D; Brignole C; Piaggio F; Perri P; Tumiatti V; Pistoia V; Pagnan G; Ponzoni M
    J Control Release; 2015 Aug; 211():44-52. PubMed ID: 26031842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice.
    Thompson J; Guichard SM; Cheshire PJ; Richmond LB; Poquette CA; Ragsdale ST; Webber B; Lorsbach R; Danks MK; Houghton PJ
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):211-21. PubMed ID: 11320664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
    Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T
    Oncotarget; 2016 Nov; 7(48):79217-79232. PubMed ID: 27764794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.